Skip to main content
Andre Nel, MD, Allergy & Immunology, Los Angeles, CA

Andre Elias Nel MD D.Sc, MMed


Distinguished Professor, Medicine, UCLA School of Medicine

Join to view full profile
  • 200 Medical Plaza#365,530,420,120Los Angeles, CA 90095

  • Phone+1 310-825-6620

Dr. Nel is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Medical University of South Carolina College of Medicine
    Medical University of South Carolina College of MedicineFellowship, Allergy and Immunology, 1983 - 1985
  • Stellenbosch University Faculty of Medicine
    Stellenbosch University Faculty of MedicineClass of 1975

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1989 - 2027
  • SC State Medical License
    SC State Medical License 1986 - 1987
  • Allergy & Immunology
    American Board of Allergy and Immunology Allergy & Immunology
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Publications & Presentations

PubMed

Journal Articles

  • Nano-Enabled Pancreas Cancer Immunotherapy Using Immunogenic Cell Death and Reversing Immunosuppression  
    Andre Nel, MD, Nature

Press Mentions

  • Chutes & Ladders—AltruBio Snags New CMO with Resume at Sublimity, Ardea, Amgen and Abbott
    Chutes & Ladders—AltruBio Snags New CMO with Resume at Sublimity, Ardea, Amgen and AbbottSeptember 17th, 2021
  • UCLA Researchers Use Nanoparticles to Develop Treatment for Allergies
    UCLA Researchers Use Nanoparticles to Develop Treatment for AllergiesFebruary 7th, 2021
  • Hitting Target in Cancer Fight Now Easier with New Nanoparticle Platform, Scientists Say
    Hitting Target in Cancer Fight Now Easier with New Nanoparticle Platform, Scientists SayMay 5th, 2011

Grant Support

  • Use of a Nano-Enabled Platform for Pancreatic Cancer ImmunotherapyUNIVERSITY OF CALIFORNIA LOS ANGELES2020–2025
  • Project 2: Relating Enm Physicochemical Properties To Mechanism-Based Pulmonary TNational Institute Of Environmental Health Sciences2010–2012
  • Center For Nanobiology And Predictive ToxicologyNational Institute Of Environmental Health Sciences2010–2012
  • Administrative CoreNational Institute Of Environmental Health Sciences2010–2012
  • Nanovalve Platform: Targeted, Controlled, Release Of Anticancer DrugsNational Cancer Institute2010–2012

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: